MA08.01 Phase 3 Trial of Whole Brain Radiotherapy With Concurrent Erlotinib Versus WBRT Alone for NSCLC With Brain Metastases (ENTER)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.376

Related search